Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine, CA 92612
Published July 13, 2016 · Recall initiated: May 10, 2016
Summary
FDA records drug Class II recall D-1064-2016, published July 13, 2016 and initiated May 10, 2016. Recalling firm: Allergan Sales, LLC; Status: Terminated; Reported quantity: 17802 units; Lot: Lot #: a) 84172, b) 84173, Exp FEB/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Content Uniformity Specifications.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Allergan Sales, LLC
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: a) 84172, b) 84173, Exp FEB/2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAKeller Funnel 2, REF: HA-001, STERILEEO, Rx Only,May 8, 2024
- FDACombigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mLNovember 22, 2017
- FDALumigan (bimatoprost ophthalmic solution) 0.01%, 2.5 mL bottle, Rx only, Allergan, Irvine, CA 92612. NDC#November 22, 2017
- FDABlephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 gJuly 5, 2017
- FDASirolimus Tablets, 1 mg, 100-count bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited,July 13, 2016
- FDAPHENYLephrine 1 mg/10 mL (100 mcg/mL) in 0.9% Sodium Chloride, 10 mL syringe, packaged in 24 syringes perJuly 13, 2016
Questions about this recall
Was Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine, CA 92612 recalled?
Yes. FDA published recall D-1064-2016 on July 13, 2016. Reported hazard: Failed Content Uniformity Specifications.
What should I do if I have this product?
Voluntary: Firm initiated · Letter